Literature DB >> 17402363

Impaired endothelial function in systemic lupus erythematosus.

M K Piper1, K Raza, S L Nuttall, R Stevens, V Toescu, S Heaton, J Gardner-Medwin, L Hiller, U Martin, J Townend, P A Bacon, C Gordon.   

Abstract

Systemic lupus erythematosus (SLE) patients suffer from excess cardiac deaths due to accelerated atherosclerosis. Endothelial dysfunction is a marker of early atherosclerosis. We tested the hypothesis that SLE patients have impaired endothelial function and assessed the relationship between endothelial function and clinical outcome over the subsequent five years. Thirty-six female SLE patients were compared with 22 healthy age and sex matched controls. Endothelial dependent vasodilatation (EDD) was assessed at the brachial artery in response to shear stress. Endothelium-independent dilatation induced by glyceryl trinitrate was also measured. Patients were followed for up to five years and the development of damage in the cardiovascular and other systems recorded. SLE patients showed significantly impaired endothelial function (median EDD 5.6%, IQR 3.1-7.2%) compared with healthy controls (median EDD 8.0%, IQR 6.3-9.3%; P = 0.001). Endothelium independent dilatation did not differ between the two groups. Endothelial function was significantly worse in postmenopausal compared with premenopausal women (median EDD 6.6%, IQR 3.9-7.8% versus 3.1%, IQR 2.6-5.1%; P = 0.016). Total cholesterol was inversely correlated with endothelial function in SLE patients (Spearman correlation r = -0.422, P = 0.025). There was no relationship between endothelial function and the development of damage in any organ system, including the cardiovascular system during patient follow-up. Patients with SLE have impaired endothelial Lupus (2007) 16, 84-88.

Entities:  

Mesh:

Year:  2007        PMID: 17402363     DOI: 10.1177/0961203306074842

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

1.  Evaluation of carotid artery elasticity changes in patients with cerebral small vessel disease.

Authors:  Xiaochun Huang; Xiaoyan Kang; Jiping Xue; Chunsong Kang; Hong Lv; Zhaojun Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus.

Authors:  J Aizer; E W Karlson; L B Chibnik; K H Costenbader; D Post; M H Liang; V Gall; M D Gerhard-Herman
Journal:  Lupus       Date:  2009-03       Impact factor: 2.911

3.  Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.

Authors:  Sokha Nhek; Robert Clancy; Kristen A Lee; Nicole M Allen; Tessa J Barrett; Emanuela Marcantoni; Janet Nwaukoni; Sara Rasmussen; Maya Rubin; Jonathan D Newman; Jill P Buyon; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

Review 4.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

5.  Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus.

Authors:  Charles Gasparovic; Clifford Qualls; Ernest R Greene; Wilmer L Sibbitt; Carlos A Roldan
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

6.  Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.

Authors:  Victoria L Wolf; Taylor L Phillips; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 7.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

8.  Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  De-Guang Wang; Xiao-Wu Tang; Ye Fan; Rui-Xue Leng; Jing Ni; Sen-Miao Deng; Chao Wang; Han Cen; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

9.  Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.

Authors:  Parasar Ghosh; Amresh Kumar; Sudeep Kumar; Amita Aggarwal; Nakul Sinha; Ramnath Misra
Journal:  Clin Rheumatol       Date:  2009-07-19       Impact factor: 2.980

Review 10.  Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease.

Authors:  Harry Choi; Domingo E Uceda; Amit K Dey; Nehal N Mehta
Journal:  Curr Rheumatol Rep       Date:  2019-12-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.